![]() |
市场调查报告书
商品编码
1833611
2032 年低温运输包装市场预测:按产品类型、包装系统、材料类型、可用性、温度要求、最终用户和地区进行的全球分析Cold Chain Packaging Market Forecasts to 2032 - Global Analysis By Product Type, Packaging System, Material Type, Usability, Temperature Requirement, End User and By Geography |
||||||
根据 Stratistics MRC 的数据,全球低温运输包装市场预计在 2025 年达到 362 亿美元,到 2032 年将达到 862 亿美元,预测期内的复合年增长率为 13.2%。
低温运输包装提供了一种隔热解决方案,可在储存和运输过程中保持对温度敏感的产品的稳定性。冷链包装对药品、生技药品、生鲜食品、水产品和乳製品至关重要,它能确保产品安全并延长保质期。全球对生鲜产品的需求不断增长,电子商务和医疗保健物流的扩张正在推动该行业的成长。相变材料、环保隔热包装和智慧包装技术的创新正在重塑这个产业。在日益严格的监管标准和生技药品产业发展的推动下,低温运输包装在全球贸易中继续发挥至关重要的作用。
生鲜产品需求不断成长
在全球范围内,生鲜食品、食材自煮包和温敏生生技药品的消费趋势正在推动製造商、零售商和物流供应商优先考虑先进的低温运输包装。此外,线上杂货店、直销食品服务和跨境医药运输的兴起,也推动了对保温容器、相变材料和主动监测的需求,以便在更长的运输时间内保持所需的温度。这种日益增长的需求正在迅速证明,全球范围内对可重复使用的智慧包装系统的投资是合理的,这些系统可以减少损耗、减轻托运人的责任、增强可追溯性、提高服务可靠性并保护产品价值。
监管挑战
各国关于温度敏感型商品、包装废弃物和材料核准的法规复杂多样,给製造商和托运人带来了沉重的合规负担。此外,关于药品低温运输资料登录、海关检查和永续性报告的规则不断演变,迫使企业重新设计包装和文件系统,并延长了前置作业时间。这些要求增加了营运成本,使全球供应链的标准化变得复杂,并且需要认证和测试。
永续包装的创新
监管压力和客户对低碳供应链日益增长的偏好,正在加速可回收、可堆肥和生物基隔热材料的采用,以及减少运输排放的轻量化设计。此外,可重复使用的容器方案和循环经营模式为减少一次性废弃物并透过资产重复使用降低成本提供了机会。纸基隔热材料、可回收容器网路和材料科学的进步,使企业能够在保持隔热性能的同时实现永续性目标。这些创新也支持品牌对环境、社会和治理 (ESG) 的承诺,并开启新的基于服务的收益来源。
气候变迁的影响
极端天气事件频繁、气温升高、运输网路中断,对低温运输的完整性构成了新的风险。热浪和暴风雨造成的延误增加了气温升高的可能性,而基础设施的压力则增加了冷藏运输和储存的成本。此外,不断变化的天气模式改变了需求的季节性,需要更具弹性的包装,以承受长时间的温差。这些压力因素将迫使供应链重新设计,增加主动系统的资本支出,并采用强有力的紧急时应对计画,提高系统的连续性,并增强系统的弹性和可靠性。
疫情凸显了低温运输包装的关键作用,因为疫苗和对温度敏感的药品需要安全运输。对隔热运输箱和干冰的需求激增,而运力限制则暴露了物流的弱点。此外,材料短缺和最后一英里的瓶颈暂时增加了成本和腐败风险。这场危机加速了对监控技术、标准化处理程序和冷藏仓库容量的投资,以增强长期韧性,并促使製造商实现供应商多元化,并重新设计包装,以加快全球分销速度。
预计预测期内,保温容器和箱子市场将占据最大份额
预计在预测期内,保温容器和保温箱领域将占据最大的市场份额。其耐用性、模组化和强大的隔热性能使其适用于各种应用,包括生鲜产品、药品和临床运输。它们在小包裹网路和托盘运输中的多功能性有助于托运人实现规模经济,同时其可重复使用的设计降低了生命週期成本。製造商正在整合监控感测器、标准化内衬和模组化内衬,以支援不同的有效载荷和运输方式,确保合规性和客户信心。
混合动力系统领域预计将在预测期内实现最高的复合年增长率
预计混合动力系统细分市场将在预测期内呈现最高成长率。对可适应热控制的需求,可降低偏移风险并优化有效载荷能力,使混合动力系统成为复杂医药和温度敏感食品物流的首选解决方案。此外,製造商正在推出模组化混合动力产品,可根据单次使用或多次使用进行客製化,从而提高托运人的投资回报率。对电池管理、云端基础监控和预测分析的持续投资将进一步加速全球商业部署并减少浪费。
预计北美将在预测期内占据最大的市场份额。强大的製药製造地、广泛的冷藏物流基础设施以及成熟的零售低温运输网路支撑着北美的主导地位。此外,人均生鲜食品消费量量高、快递小包裹网路完善以及先进活性包装的早期采用也支撑了市场需求。在冷藏设施、自动化、法规合规性和技术整合方面的大量投资增强了该地区的长期优势。
预计亚太地区在预测期内的复合年增长率最高。冷藏基础设施的快速扩张、製药业的成长以及生鲜电商配送需求的不断增长,正在推动该地区的成长。印度、中国和东南亚各国政府正在投资冷藏物流和疫苗接种项目,而当地包装公司也在扩大生产规模,并采用混合和永续材料。此外,公路和铁路连通性的改善、跨境贸易的便利化以及与私营部门的合作,正迅速推动冷藏技术的普及。
According to Stratistics MRC, the Global Cold Chain Packaging Market is accounted for $36.2 billion in 2025 and is expected to reach $86.2 billion by 2032 growing at a CAGR of 13.2% during the forecast period. The Cold Chain Packaging provides insulated solutions to maintain temperature-sensitive products during storage and transportation. Essential for pharmaceuticals, biologics, fresh produce, seafood, and dairy, this market ensures product safety and shelf-life extension. Growth is driven by rising global demand for perishable goods, expanding e-commerce, and healthcare logistics. Innovations in phase change materials, eco-friendly insulation, and smart packaging technologies are reshaping the sector. With stricter regulatory standards and the growing biologics industry, cold chain packaging continues to play a pivotal role in global trade.
Rising Demand for Perishable Goods
The global shift toward fresh produce, meal kits and temperature-sensitive biologics has driven manufacturers, retailers and logistics providers to prioritize advanced cold chain packaging. Furthermore, growth in online grocery, direct-to-consumer food services and cross-border pharmaceutical shipments requires insulated containers, phase-change materials and active monitoring to maintain required temperatures across longer transit times. This rising demand reduces spoilage, lowers liability for shippers and justifies investment in reusable and intelligent packaging systems that enhance traceability improve service reliability and safeguard product value, rapidly worldwide.
Regulatory Challenges
Complex and varying national regulations for temperature-sensitive goods, packaging waste and materials approval create significant compliance burdens for manufacturers and shippers. Additionally, evolving rules for pharmaceutical cold chain data logging, customs inspections and sustainability reporting force firms to redesign packaging and documentation systems, extending lead times. These requirements increase operational costs, complicate standardization across global supply chains and demand certification and testing.
Sustainable Packaging Innovations
Growing regulatory pressure and customer preference for lower-carbon supply chains are accelerating recyclable, compostable and bio-based insulating materials, alongside lighter-weight designs that reduce transport emissions. Moreover, reusable container schemes and circular business models present cost-saving opportunities through reduced single-use waste and repeated asset utilization. Advances in paper-based insulators, returnable crate networks and materials science enable firms to meet sustainability targets while maintaining thermal performance. These innovations also support brand commitments to ESG and open new service-based revenue streams.
Climate Change Impacts
Increasing frequency of extreme weather events, rising ambient temperatures and disrupted transport networks create new risks for cold chain integrity. Heatwaves and storm-related delays raise the probability of temperature excursions, while infrastructure strain increases costs for refrigerated transport and storage. Additionally, shifting climate patterns alter demand seasonality and require more resilient packaging that can withstand longer exposures to temperature variance. These stressors force supply chain redesign, higher capital expenditure on active systems and adoption of robust contingency planning, continuity, and increase system resilience and confidence.
The pandemic highlighted cold chain packaging's critical role as vaccines and temperature-sensitive medicines required secure transport. Demand spiked for insulated shippers and dry ice while capacity constraints exposed logistics weaknesses. Additionally, material shortages and last-mile bottlenecks temporarily increased costs and risk of spoilage. The crisis accelerated investment in monitoring technologies, standardized handling protocols and cold storage capacity, strengthening long-term resilience and prompting manufacturers to diversify suppliers and redesign packaging for faster global distribution.
The insulated containers/boxes segment is expected to be the largest during the forecast period
The insulated containers/boxes segment is expected to account for the largest market share during the forecast period. Insulated containers and boxes combine durability, modularity and strong thermal performance, making them preferred for a broad range of perishable goods, pharmaceuticals and clinical shipments. Their versatility across parcel networks and palletized transport supports economies of scale for shippers, while reusable designs lower lifecycle costs. Manufacturers are integrating monitoring sensors, standardized inserts and modular liners to support diverse payloads and shipping modes, helping ensure compliance and customer confidence.
The hybrid systems segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the hybrid systems segment is predicted to witness the highest growth rate. Demand for adaptable thermal control that reduces excursion risk while optimising payload volume positions hybrid systems as a preferred solution for complex pharmaceutical and temperature-sensitive food logistics. Additionally, manufacturers are introducing modular hybrid products tunable for single-use or multi-use cycles, improving ROI for shippers. Continued investment in battery management, cloud-based monitoring and predictive analytics will further accelerate commercial deployment worldwide and reduce waste.
During the forecast period, the North America region is expected to hold the largest market share. Strong pharmaceutical manufacturing bases, extensive refrigerated logistics infrastructure and mature retail cold chain networks underpin North America's leading position. Additionally, high per-capita consumption of fresh and processed perishable foods, established express parcel networks and early adoption of advanced active packaging support demand. Large investments in cold storage facilities, automation, regulatory compliance and technological integration reinforce long-term dominance in the region.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. Rapid expansion of cold storage infrastructure, growing pharmaceutical manufacturing and increasing demand for fresh e-commerce deliveries are accelerating regional growth. Governments in India, China and Southeast Asia are investing in refrigerated logistics and vaccination programmes, while local packaging suppliers scale production and adopt hybrid and sustainable materials. Moreover, improving road and rail connectivity, cross-border trade facilitation and private sector partnerships spur adoption rapidly.
Key players in the market
Some of the key players in Cold Chain Packaging Market include Sonoco ThermoSafe, Peli BioThermal, CSafe Global, va-Q-tec, Cryoport Systems, Cold Chain Technologies (CCT), Cryopak, Intelsius, Sofrigam, Nordic Cold Chain Solutions, Ember Technologies, Orora Group, Veritiv, Sensitech, and Timestrip.
In January 2025, Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or "the Company"), a global leader in supply chain solutions for the life sciences unveiled its Cryoport Express(R) Cryogenic HV3 Shipping System ("HV3"), the Company's newest product innovation in Cryoport's comprehensive portfolio of global end-to-end temperature-controlled supply chain offerings.
In November 2023, va-Q-tec has developed a new phase-change material (PCM) that enables transport at -70 °C without the use of dry ice. Using the new PCM cultures for cell and gene therapy and other items can be transported safely for up to 72 hours. The solution reduces transport risks and eases restrictions caused by dry ice.
In September 2022, Peli BioThermal has announced a new reusable, flexible, temperature-controlled shipping solution. It says Credo Go is designed to adapt to customer programs, as well as helping pharmaceutical companies reach environmental, social and governance goals, cost reduction targets and operational performance indicators.
"
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.